1. Home
  2. TENX vs FVCB Comparison

TENX vs FVCB Comparison

Compare TENX & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.79

Market Cap

317.8M

Sector

Health Care

ML Signal

N/A

Logo FVCBankcorp Inc.

FVCB

FVCBankcorp Inc.

N/A

Current Price

$18.49

Market Cap

338.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
FVCB
Founded
1967
2007
Country
United States
United States
Employees
N/A
125
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
338.0M
IPO Year
2001
2018

Fundamental Metrics

Financial Performance
Metric
TENX
FVCB
Price
$1.79
$18.49
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$29.67
$18.00
AVG Volume (30 Days)
7.9M
76.5K
Earning Date
05-15-2026
04-21-2026
Dividend Yield
N/A
1.80%
EPS Growth
N/A
47.56
EPS
N/A
0.81
Revenue
N/A
$1,781,000.00
Revenue This Year
N/A
$13.83
Revenue Next Year
N/A
$7.45
P/E Ratio
N/A
$22.62
Revenue Growth
N/A
13.87
52 Week Low
$1.31
$11.83
52 Week High
$19.40
$19.11

Technical Indicators

Market Signals
Indicator
TENX
FVCB
Relative Strength Index (RSI) 19.03 52.30
Support Level $1.31 $18.12
Resistance Level $16.39 $19.11
Average True Range (ATR) 0.55 0.35
MACD -0.78 -0.09
Stochastic Oscillator 3.48 37.14

Price Performance

Historical Comparison
TENX
FVCB

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: